A mononuclear copper(II) complex based on the polypyridyl ligand 2,4,6-tris(2-pyridyl)-1,3,5-triazine (tptz), [Cu(tptz)2]2+: X-ray crystal structure, DNA binding and in vitro cell cytotoxicity

(Un)suitability of the use of pH buffers in biological, biochemical and environmental studies and their interaction with metal ions – a review

“…These studies involve proteins with heme groups, [134][135][136] Zn-nger motifs, [137][138][139] metalloproteins 116,133,[140][141][142] and/or other complexing agents in solution. 81,[143][144][145] In fact, the concentrations of the compounds used, and most importantly the ratio of the buffer concentration to the complexing compound concentration in the medium, are within values that support the idea that no interference of the buffer occurs.…”

A mononuclear Cu(II) complex with 5,6-diphenyl-3-(2-pyridyl)-1,2,4-triazine: Synthesis, crystal structure, DNA- and BSA-binding, molecular modeling, and anticancer activity against MCF-7, A-549, and HT-29 cell lines

“…Also, the migration of the complex-DNA bands is gradually retarded as the concentration of the Cu(II) complex is increased. These results show that the Cu(II) complex can bind to DNA and change the size and/or shape of DNA[63,65].…”

A mononuclear Ni(II) complex with 5,6-diphenyl-3-(2-pyridyl)-1,2,4-triazine: DNA- and BSA-binding and anticancer activity against human breast carcinoma cells

“…[EB] = 1.0 lM, K EB = 1.0 Â 10 7 M À1 [46], and the complex concentration was the value at 50% reduction of the fluorescence intensity of EB. The K app value was calculated to be 0.83 Â 10 7 M À1 .…”